Argyris Symeonidis

42PUBLICATIONS
155CO-AUTHORS
Social epidemiologyRespiratory diseasesPharmacogenomicsMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 30, 2026
The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

|Feb 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Aleksandar Savic, Adele Taylor, Pierre Fenaux

|Jan 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.

Noemi Puig, Xavier Leleu, Hans C Lee

|Jul 23, 2025
The Transcription Axes ERK-Elk1, JNK-cJun, and JAK-STAT Promote Autophagy Activation and Proteasome Inhibitor Resistance in Prostate Cancer Cells.

Georgios Kalampounias, Kalliopi Zafeiropoulou, Theodosia Androutsopoulou

|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).

Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos

|May 06, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Anthi Bouchla, Sotirios G Papageorgiou, Ioannis Kotsianidis

Pageof 7

Frequent Collaborators

6 joint publications

Panagiotis T Diamantopoulos

5 joint publications

Eleftheria Hatzimichael

5 joint publications

Eirini Katodritou

5 joint publications

Evangelos Terpos